---
schema_version: "secwatch.filing_event.v1"
accession: "0001787306-24-000090"
form_type: "8-K"
ticker: "ARQT"
cik: "0001787306"
company_name: "Arcutis Biotherapeutics, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:56:45.672016+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Arcutis stockholders elect three directors, ratify EY, approve say-on-pay at 2024 annual meeting

## Summary
- All three Class I director nominees elected: Terrie Curran (77.2M for), Halley Gilbert (75.8M for), Keith R. Leonard Jr. (59.3M for).
- Ratification of Ernst & Young as auditor for FY2024 passed with 95,949,963 votes for, 6,661 against.
- Non-binding advisory vote on named executive officer compensation approved: 56,906,215 for, 26,716,602 against.
- Meeting held June 14, 2024; record date April 22, 2024 with 115,524,989 shares outstanding and entitled to vote.
- Broker non-votes of 12,428,038 on director election and say-on-pay proposals, none on auditor ratification.

## SEC filing metadata
- accession: 0001787306-24-000090
- form_type: 8-K
- ticker: ARQT
- cik: 0001787306
- company_name: Arcutis Biotherapeutics, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787306/000178730624000090/0001787306-24-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787306/000178730624000090/arqt-20240614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787306-24-000090
- JSON: https://secwatch.observer/filing/0001787306-24-000090.json
- Plain text: https://secwatch.observer/filing/0001787306-24-000090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.